metastasis
Several new studies appear to confirm the test's potential to prevent overtreatment of melanoma patients while identifying those at high risk.
Pathomiq, Neuberg Diagnostics Partner to Launch Prostate Cancer Recurrence Test
The companies aim to first introduce the machine learning-based test, which analyzes histopathology slides to predict prostate cancer relapse and metastasis, in the US.
SkylineDx Gains CE-IVD Mark for Melanoma Metastasis Risk Assay
The Netherlands-based firm is partnering with Belgian company Biocartis on European commercialization of the qPCR assay, which could reduce unnecessary surgeries.
Plus Therapeutics, Biocept Ink Lab Services Agreement for ReSPECT-LM Trial
Biocept will test patients with its CNSide cerebrospinal fluid cell capture assay to evaluate responses to Plus' radiotherapy drug candidate.
Biocept to Refocus CNSide Assay Plans After FDA Feedback Suggests Targeting Narrower Indications
Premium
The company failed in its first bid for breakthrough device designation but has now split out new specific indications for which it is building more persuasive utility data.